Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 3,476,000 | 2,919,000 | 2,673,000 | 2,664,000 | 2,842,000 |
| Cost of Goods | 961,000 | 870,000 | 919,000 | 832,000 | 986,000 |
| Gross Profit | 2,515,000 | 2,049,000 | 1,754,000 | 1,832,000 | 1,856,000 |
| Operating Expenses | 1,818,000 | 1,439,000 | 1,654,000 | 1,252,000 | 1,131,000 |
| Operating Income | 697,000 | 610,000 | 100,000 | 580,000 | 725,000 |
| Interest Expense | 46,000 | 43,000 | 59,000 | 70,000 | 118,000 |
| Other Income | -8,000 | -18,000 | 3,000 | 17,000 | -45,000 |
| Pre-tax Income | 643,000 | 549,000 | 44,000 | 527,000 | 562,000 |
| Income Tax | 171,000 | 176,000 | 98,000 | 154,000 | 191,000 |
| Net Income Continuous | 472,000 | 373,000 | -54,000 | 373,000 | 364,000 |
| Net Income | $472,000 | $373,000 | $-54,000 | $373,000 | $371,000 |
| EPS Basic Total Ops | 0.57 | 0.46 | -0.07 | 0.46 | 0.45 |
| EPS Basic Continuous Ops | 0.57 | 0.46 | -0.07 | 0.46 | 0.44 |
| EPS Diluted Total Ops | 0.56 | 0.45 | -0.07 | 0.46 | 0.45 |
| EPS Diluted Continuous Ops | 0.56 | 0.45 | -0.07 | 0.46 | 0.44 |
| EBITDA(a) | $893,000 | $771,000 | $332,000 | $761,000 | $903,000 |